Skip to content

Evaluate Anti-adhesive Effect and Safety of a Mixed Solid of Poloxamer, Gelatin and Chitosan(Mediclore®)

Evaluate Anti-adhesive Effect and Safety of a Mixed Solid of Poloxamer, Gelatin and Chitosan(Mediclore®) for Intraperitoneal Adhesion in Patient With Gynecological Surgery, a Multicenter Single-blinded, Randomized Study

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03007654
Acronym
antiadhesion
Enrollment
192
Registered
2017-01-02
Start date
2016-12-31
Completion date
2017-08-31
Last updated
2017-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecologic Disease

Brief summary

The purpose of this study is to evaluate the efficacy and safety of Mediclore®, as an antiadhesive barrier, which is made of Poloxamer, Gelatin and Chitosan.

Interventions

DEVICEMediclore

apply medical device fully around intrauterine surgery area

DEVICEAdept

apply medical device fully around intrauterine surgery area

Sponsors

Yong Sang Song
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with Gynecological disease (benign disease) * Patients who Written informed consent * Patients without clinically significant lab

Exclusion criteria

* having enrolled another clinical trials within 1 month * Immunosuppression or autoimmune disease * Anticoagulant, general steroids within a week from surgery * Serious diseases (heart failure, renal failure, liver failure, uncontrolled hypertension, diabetes mellitus, coagulation deficiencies) * Patients with previous history of surgery at the same operate site

Design outcomes

Primary

MeasureTime frameDescription
adhesion rate4 weeks after surgery4 weeks after surgery, finding adhesion using visceral slide test

Secondary

MeasureTime frameDescription
Incidence of adhesion symptoms4 weeks after surgery4 weeks after surgery, Identifying adhesion sysmptoms using Questionnaire
adverse event4 weeks after surgeryidentifying adverse events after surgery

Countries

South Korea

Contacts

Primary ContactYongsang Song, MD
yssong@snu.ac.kr+82-10-9580-1023
Backup ContactMaria Lee, MD
marialee@snu.ac.kr+82-10-2991-9692

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026